May 11 () - GSK said on Monday it had entered into a strategic collaboration with Hong Kong-listed Sino Biopharmaceutical ...
The agreement with Sino Bio, via its subsidiary Chia Tai Tianqing Pharma (CTTQ), allies GSK with a company that is one of ...
May 11 (Reuters) - Britain's GSK said on Monday it signed a deal with Hong Kong-listed Sino Biopharmaceutical to expand its ...
Thousands of patients at a dental practice are being warned that they may have been exposed to bloodborne viruses.
Hepatitis affects 287 million globally, often undetected until severe liver damage, says the WHO. Early testing, awareness, ...
GSK today announced that it has filed a new drug submission for bepirovirsen for regulatory review in Canada. Bepirovirsen is ...
Gyre Therapeutics, Inc. ('Gyre”, 'Gyre Therapeutics” or the 'Company”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company with operations in the United States and China, today ...
The World Health Organization on Tuesday said progress in eliminating hepatitis was too slow, with tools available to eliminate the disease that kills more than one million people annually.
Countries are making measurable progress in combatting viral hepatitis, but the disease remains a major global health challenge, the World Health Organization (WHO) said in a new report published on ...
Viral hepatitis B and C—the two forms responsible for 95% of hepatitis-related deaths—claimed an estimated 1.34 million lives in 2024.
Despite combination prophylaxis with HBIG and NUCs transforming outcomes after liver transplantation for hepatitis B, some ...
FDA regulatory momentum includes priority review and breakthrough therapy designation for a potential first-in-class CHB ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results